Influence of obesity and body fat distribution on postprandial lipemia and triglyceride-rich lipoproteins in adult women

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 1, 1999, Pages 184-191

  Mekki, N ^a   Christofilis, M A ^b   Charbonnier, M ^a   Atlan Gepner, C ^b   Defoort, C ^a,c   Juhel, C ^a   Borel, P ^d   Portugal, H ^c   Pauli, A M ^c   Vialettes, B ^b   Lairon, Denis ^a  

^a INSERM   (France)

^b Hôpital Ste Marguerite   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; CHYLOMICRON; LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY DISTRIBUTION; BODY FAT; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; LIPID DIET; LIPID METABOLISM; METABOLIC DISORDER; OBESITY; PHENOTYPE; POSTPRANDIAL STATE; PRIORITY JOURNAL;

ADIPOSE TISSUE; ADULT; APOLIPOPROTEIN C-III; APOLIPOPROTEINS C; FEMALE; HUMANS; INSULIN; INTESTINES; LIPOPROTEIN LIPASE; LIPOPROTEINS; LIVER; MIDDLE AGED; OBESITY; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 0032926382     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.1.184     Document Type: Article

References (59)

1. 1. Manson JE, Colditz GA, Stampfer MJ, et al. 1990 A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med. 322:882-889.
2. 2. Després JP. 1994 Dyslipidemia and obesity. Baillières Clin Endocrinol Metab. 8:629-658.
3. 3. Vague J. 1956 The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout and uric calculous disease. Am J Clin Nutr. 4:20-34.
4. 4. Kissebah AH, Vydelingum N, Murray R, et al. 1982 Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab. 54:254-260.
5. 5. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L. 1994 Abdominal adipose tissue and risk of cardiovascular disease and death: a ten-year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J. 289:1261-1263.
6. 6. Björntorp P. 1991 Metabolic implication of body fat distribution. Diabetes. 14:1132-1143.
7. 7. Després JP, Moorjani S, Ferland M, et al. 1989 Adipose tissue distribution and plasma lipoprotein levels in obese women. Arterioscler Thromb. 9:203-210.
8. 8. Després JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. 1990 Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arterioscler Thromb. 10:497-511.
9. 9. Fontbonne A, Eschwege E, Cambien F, et al. 1989 Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Diabetologia. 37:300-304.
10. 10. Maheux P, Azhar S, Kern PA, Chen Y-DI, Reaven GM. 1997 Relationship between insulin-mediated glucose disposal and regulation of plasma and adipose tissue lipoprotein lipase. Diabetologia. 40:850-858.
11. 11. Pouliot MC, Després JF, Nadeau A, et al. 1992 Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes. 41:826-834.
12. 12. Reaven GM. 1988 Role of insulin resistance in human disease. Diabetes. 37:1595-1607.
13. 13. Brinton EA, Eisenberg S, Breslow JL. 1994 Human HDL cholesterol levels are determined by Apo A-1 fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution. Arterioscler Thromb. 14:707-720.
14. 14. Kern PA, Ong JM, Saffari B, Carty J. 1990 The effects of weight loss on the activity and expression of adipose-tissue lipoprotein lipase in very obese humans. N Engl J Med. 322:1053-1059.
15. 15. Björkegren J, Hamsten A, Milne RW, Karpe F. 1997 Alterations of VLDL composition during alimentary lipemia. J Lipid Res. 38:301-314.
16. 16. Attman PO, Alaupovic P, Tavella M, Knight-Gibson C. 1996 Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure. Nephrol Dial Transplant. 11:63-69.
17. 17. Castro Cabezas M, de Bruin TWA, de Valk HW, Shoulders CC, Jansen H, Erkelens DW. 1993 Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance. J Clin Invest. 92:160-168.
18. 18. de Silva HV, Lauer SJ, Wang J, et al. 1994 Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B-48 remnants that is corrected by excess apolipoprotein E. J Biol Chem. 269:2324-2335.
19. 19. Li X, Grundy S, Pastel SB. 1997 Obesity in db and ob animals leads to impaired hepatic very low density lipoprotein secretion and differential secretion of apolipoprotein B48 and B100. J Lipid Res. 38:1277-1288.
20. 20. Dubois C, Armand M, Azais-Braesco V, et al. 1994 Effects of moderate amounts of emulsified dietary fat on postprandial lipemia and lipoproteins in normolipidemic adults. Am J Clin Nutr. 60:374-82.
21. 21. De Man FHAF, Castro Cabezas M, Van Barlingen HHJJ, Erkelens DW, De Bruin TNA. 1996 Triglyceride-rich lipoproteins in non-insulin-dependent diabete mellitus: postprandial metabolism and relation to premature atherosclerosis. Eur J Clin Invest. 26:89-108.
22. 22. Zilversmit DB. 1979 Atherogenesis: a postprandial phenomenon. Circulation. 60:473-485.
23. 23. Weintraub MS, Eisenberg S, Breslow JL. 1987 Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals: effect of treatment with cholestyramine and gemfibrozil. J Clin Invest. 79:1110-1119.
24. 24. Miesenböck G, Patsch JR. 1992 Postprandial hyperlipidemia: the search for atherogenic lipoprotein. Curr Opin Lipidol. 3:196-201.
25. 25. Patsch JR, Miesenböck G, Hopferwieser T, et al. 1992 Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb. 12:1336-1345.
26. 26. Havel R. 1994 Triglyceride-rich lipoproteins and atherosclerosis-new perspectives. Am J Clin Nutr. 59:795-799.
27. 27. Juhel C, Dubois C, Senft M, Levy E, Lafont H, Lairon D. 1997 Postprandial lipemia is exacerbated in fat-cholesterol-fed rabbits: relationship to atheroma deposition. Br J Nutr. 78:301-311.
28. 28. Lewis GF, O'Meara NM, Soltyts PA, et al. 1990 Postprandial lipoprotein metabolism in normal and obese subjects: comparison after vit A fat-loading test. J Clin Endocrinol Metab. 71:1041-1050.
29. 29. Coppack SW, Evans RD, Fisher RM, et al. 1992 Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal. Metabolism. 41:264-272.
30. 30. Raben A, Andersen HB, Christensen NJ, et al. 1994 Evidence for abnormal postprandial response to a high-fat meal in women predisposed to obesity. Am J Physiol. 30:E549-E559.
31. 31. Potts JL, Coppack SW, Fisher PM, Humphreys SM, Gibbons GF, Frayn KN. 1995 Impaired postprandial clearance of triacylglycerol-rich lipoproteins in adipose tissue in obese subjects. Am J Physiol. 268:E588-E594.
32. 32. Ginsberg HN, Jones J, Blaner WS, et al. 1995 Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women. Arterioscler Thromb Vasc Biol. 11:1829-1838.
33. 33. Ditschuneitt HH, Flechtner-Mors M, Hagel E, Ditschuneitt H. 1992 Postprandial lipoprotein metabolism in obese patients with moderate hypertriglyceridemia: effects of gemfibrozil. J Int Med Res. 20:197-210.
34. 34. Wideman L, Kaminsky LA, Whaley MH. 1996 Postprandial lipemia in obese men with abdominal fat patterning. J Sports Med Phys Fitness. 36:204-210.
35. 35. Couillard C, Bergeron N, Prud'homme D, et al. 1998 Postprandial triglyceride response in visceral obesity in men. Diabetes. 47:953-960.
36. 36. Dubois C, Beaumier G, Juhel C, et al. 1998 Effects of graded amounts (0-50 g) of dietary fat on postprandial lipemia and lipoproteins in normolipidemic adults. Am J Clin Nutr. 67:31-38.
37. 37. Charbonnier M, Lechène de la Porte P, Veesler S, et al. 1995 Particle size analysis. Inter Labmate. 37-39.
38. 38. Kosykh VA, Novikov DK, Trakht IN, et al. 1991 Effect of chylomicronremnants on cholesterol metabolism in cultured rabbit hepatocytes: very low lipoprotein and bile acid production. Lipids. 10:799-805.
39. 39. Cohn JS, Johnson EJ, Millar JS, et al. 1993 Contribution of apoB-48 and apoB-100 triglyceride-rich lipoprotein (TRL) to postprandial increases in plasma concentration of TRL triglycerides and retinyl esters. J Lipid Res. 34:2033-2039.
40. 40. Karpe F, Hamsten A. 1994 Determination of apolipoprolein B48 and B100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. J Lipid Res. 35:1311-1317.
41. 41. Buccolo G, David H. 1973 Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 19:476-482.
42. 42. Siedel J, Hägele EO, Ziegenhorn J, Wahlefeld AW. 1983 Reagent for enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem. 29:1075-1080.
43. 43. Takayama M, Itoh S, Nagasaki T, Tanimizu I. 1977 A new enzymatic method for choline containing phospholipids. Clin Chim Acta. 79:93-98.
44. 44. Horvath KW, Pomare H. 1976 Immobilized enzymes in continuous-flow analysis. In: Advances in automated analysis. Technicon International Congress, Vol 1. Tarrytown, NY: Mediated Inc; 86-95.
45. 45. Hixson JE, Vernier DT. 1990 Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 31:545-548.
46. 46. Arnqvist H, Olsson PO, Von Schenck H. 1987 Free and total insulin as determined after precipitation with polyethylene glycol: analytical characteristics and effects of sample handling and storage. Clin Chem. 33:93-96.
47. 47. Krauss RM, Levy RI, Frederickson DS. 1974 Selective measurements of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia. J Clin Invest. 54:1170-1124.
48. 48. Curtin A, Deegan P, Owens D, Collins P, Johnson A, Tomkin GH. 1996 Elevated triglyceride-rich-lipoproteins in diabetes. A study of apolipoprotein B-48. Acta Diabetol. 33:205-210.
49. 49. Lewis GF, O'Meara NM, Soltys PA, et al. 1991 Fasting hypertriglyceridemia in non-insulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities. J Clin Endocrinol Metab. 72:934-944.
50. 50. Ryu JE, Howard G, Craven TE, Bond MG, Hagaman AP, Crouse JR. 1992 Postprandial triglyceridemia and carotid atherosclerosis in middie-aged subjects. Stroke. 23:823-828.
51. 51. Martins IJ, Mortimer BC, Miller J, Redgrave TG. Effects of particle size and number on the plasma clearance of chylomicrons and remnants. J Lipid Res. 1996:37:2696-2705.
52. 52. Stalenhoef AFH, Malloy MJ, Kane JP, Havel R. 1984 Metabolism of apolipoprotein B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoproteins lipase-deficient humans. Proc Natl Acad Sci USA. 81:1839-1843.
53. 53. Rensen PCN, Herijgers N, Netscher MH, Meskers SCJ, van Eck M, van Berkel TJC. 1997 Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor vs. hepatic remnant receptor in vivo. J Lipid Res. 38:1070-1084.
54. 54. Schonfeld G, George PK, Miller J, Reilly P, Witzum J. 1979 Apolipoprotein C-II and C-III levels in hyperlipoproteinemia. Metabolism. 28:1001-1010.
55. 55. Fredenrich A, Giroux LM, Tremblay M, Krimbou L, Davignon J, Cohn JS. 1997 Plasma lipoprotein distribution of apo C-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions. J Lipid Res. 38:1421-1432.
56. 56. Wang CS, McConathy WJ, Kloer HU, Alaupovic P. 1985 Modulation of lipoprotein activity by apolipoproteins. Effect of apolipoprotein C-III. J Clin Invest. 75:384-390.
57. 57. Windler E, Havel RJ. 1985 Inhibitory effect of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by perfused rat liver. J Lipid Res. 26:556-565.
58. 58. Frayn KN. 1993 Insulin resistance and lipid metabolism. Curr Opin Lipidol. 4:197-204.
59. 59. Jeppesen J, Hollenbeck CB, Zhore MY, et al. 1995 Relation between insulin resistance, hyperinsulinemia, postheparin plasma, lipoprotein lipase activity and postprandial lipemia. Arterioscler Thromb Vasc Biol. 15:320-324.